API
< Back to situations

[ORGANIZATION]

Sanofi

Featured in 61 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [CH]

Novartis remibrutinib clinical development

3 clusters · 12 sources · last updated

Latest: Novartis projects $4 billion in peak sales for MS drug remibrutinib

Novartis is advancing the clinical application of remibrutinib, an oral Bruton tyrosine kinase (BTK) inhibitor, across different medical indications. In October 2026, the US Food and Drug Administration (FDA) approved r

[ACTIVE] [HEALTH] [VN] [FR]

Influenza vaccine rollouts in Vietnam

2 clusters · 3 sources · last updated

Latest: VNVC and Sanofi launch specialized flu vaccine for elderly in Vietnam

The VNVC Vaccination System has introduced new influenza vaccine options in Vietnam targeting different age demographics. On October 28, 2026, AstraZeneca launched a needle-free nasal spray vaccine for children and adol

[ACTIVE] [HEALTH] [IT]

Italy influenza, COVID-19 and RSV vaccination rollout

24 clusters · 217 sources · last updated

Latest: Lombardy exceeds 1 million influenza vaccine doses administered

The 2026-2027 seasonal vaccination campaign in Italy, targeting influenza, COVID-19, and Respiratory Syncytial Virus (RSV), is underway. Following authorization of updated influenza vaccines by AIFA and the EMA, the camp

[ACTIVE] [TECHNOLOGY] [IN] [US] [DE]

Global evolution of healthcare AI and digital integration

24 clusters · 69 sources · last updated

Latest: Technology and AI transform patient communication and telehealth

The healthcare sector is undergoing a profound shift toward technology-enabled growth, characterized by the integration of artificial intelligence, cloud computing, and physical AI. The global healthcare predictive analy

[ACTIVE] [HEALTH] [PK] [DE]

Medical supply shortages in Pakistan

2 clusters · 5 sources · last updated

Latest: Pakistan faces influenza vaccine shortages and counterfeit seizures

Pakistan is experiencing shortages of critical medical supplies, including insulin and influenza vaccines. In late October, a shortage of a specific insulin product for Type 1 diabetes patients emerged following a supp

[ACTIVE] [BUSINESS] [DE] [FR] [BE]

Sanofi EU antitrust settlement over influenza vaccine

2 clusters · 6 sources · last updated

Latest: Sanofi reaches agreement with European Commission over flu vaccine messaging

Sanofi has reached an agreement with the European Commission to resolve an antitrust investigation into the marketing of its influenza vaccine, Efluelda. The investigation examined whether the company used misleading cla

[ACTIVE] [HEALTH] [RO] [BG] [CZ]

2026/2027 influenza vaccination rollout

9 clusters · 51 sources · last updated

Latest: Flu vaccine distribution begins in North Macedonia and Bulgaria

For the 2026/2027 influenza season, health authorities have updated vaccine compositions to align with World Health Organization guidelines. In the Czech Republic, the National Institute of Public Health (SZÚ) noted that

[QUIET] [BUSINESS] [DE] [IT]

Sanofi pharmaceutical manufacturing expansion in Europe

2 clusters · 8 sources · last updated

Latest: Sanofi invests 2 billion euros in new insulin plant in Frankfurt

Sanofi is expanding its pharmaceutical manufacturing footprint across Europe through specialized production initiatives. In Italy, the company is shifting the focus of its Anagni site toward rare diseases, specifically

[QUIET] [HEALTH] [FR] [CH]

France launches joint influenza and COVID-19 campaign

10 clusters · 29 sources · last updated

Latest: France implements mandatory prescription for flu vaccines

France has launched its annual joint influenza and COVID-19 vaccination campaign for the 2026-2027 season, which officially began in mainland France on October 13, 2026. The campaign is scheduled to run through January 3

[QUIET] [INTERNATIONAL] [VN] [AU] [FR]

Vietnam's expanding global diplomacy and tech partnerships

26 clusters · 97 sources · last updated

Latest: Vietnam President To Lam calls for trade-facilitating legislative reforms

Following President To Lam’s August state visits to Australia and New Zealand, Vietnam has continued to expand its global diplomatic and economic footprint. In mid-August 2026, To Lam held high-level meetings in Hanoi wi

[QUIET] [BUSINESS] [CN] [CA] [MD]

Preparations for 9th China International Import Expo

4 clusters · 8 sources · last updated

Latest: China International Import Expo to be held in Shanghai this November

Preparations for the 9th China International Import Expo (CIIE), scheduled for November 5 to 10 at the National Exhibition and Convention Center in Shanghai, have reached new milestones. The event is expected to host 162

[QUIET] [HEALTH] [VN] [FR]

Vaccine production and distribution in Vietnam

3 clusters · 13 sources · last updated

Latest: VNVC administers 100,000 hand, foot, and mouth disease vaccine doses in Vietnam

Vietnam is expanding its domestic vaccine production and availability through various international partnerships. In September 2026, the Vietnam Vaccine Company (VNVC) and Sanofi signed a declaration to produce three gen

[QUIET] [BUSINESS] [PL] [ES] [IT]

Adamed Pharma European expansion

2 clusters · 4 sources · last updated

Latest: ADAMED Pharma to invest 100 million euros in Spanish manufacturing plant

Polish pharmaceutical and biotechnology company Adamed Pharma has undertaken significant expansion efforts across Europe through strategic acquisitions and investments. In July 2026, the company finalized an investment

[QUIET] [CULTURE] [MX] [AR]

Yolanda Andrade health status

4 clusters · 21 sources · last updated

Latest: Yolanda Andrade receives support from colleagues amid health battles

Mexican television presenter Yolanda Andrade recently returned to the program ‘Montse & Joe’ on Unicable following a period of intermittent appearances. During her return, Andrade spoke about her health struggles, statin

[QUIET] [BUSINESS] [CH] [US] [CN]

Pharmaceutical industry drug discovery partnerships

2 clusters · 6 sources · last updated

Latest: Novartis and Sanofi lead major pharmaceutical licensing and alliance expansions

Major pharmaceutical companies are entering large-scale partnerships to advance drug discovery and development through specialized technologies. In late September 2026, Boehringer Ingelheim expanded its collaboration wi

Also covered in